Stable Mixed Chimerism and Tolerance of Vascularized Composite Allografts via Bcl-2 Inhibition
Abstract
The project aims to develop a clinically applicable nontoxic conditioning regimen with selective Bcl-2 inhibition for induction of mixed chimerism and VCA tolerance.In the first year, the focus was on preparing the field (getting the protocols approved, screening acquiring non-human primates, drugs and reagents) and starting the surgeries .
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2023
- Accession Number
- AD1229239
Entities
People
- Curtis L. Cetrulo, Jr
Organizations
- Massachusetts General Hospital